Covalon Reports Fourth Consecutive Quarter of Year over Year Revenue Growth and Positive Earnings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 21 2025
0mins
Source: Businesswire
Financial Performance: Covalon Technologies reported a 75% increase in revenue for Q1 of fiscal 2025, driven by strong growth in its US Medical Consumables business, resulting in significant improvements in gross profit and earnings compared to the previous year.
Recent Achievements: The company was recognized as a top performer in both TSX Ventures and OTCQX rankings, secured a new patent for its VALGuard® Line Guard product line, and experienced substantial growth in its Vascular Access and Surgical Consumables business.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
